Lv1
30 积分 2021-09-23 加入
Mitigating the risk of cytokine release syndrome in a Phase I trial of CD20/CD3 bispecific antibody mosunetuzumab in NHL: impact of translational system modeling
4天前
已完结
An FDA oncology analysis of antibody-drug conjugates
26天前
已完结
Review of dose justifications for antibody-drug conjugate approvals from clinical pharmacology perspective: A focus on exposure-response analyses
1个月前
已完结
Flat dose regimen of toripalimab based on model-informed drug development approach
2个月前
已完结
Multiple‐Dose Pharmacokinetics, Safety, and Tolerability of Aprocitentan, a Dual Endothelin Receptor Antagonist, in Healthy Japanese and Caucasian Subjects
4个月前
已完结
DX‐8951f: Summary of Phase I Clinical Trials
5个月前
已完结
Transition of average drug‐to‐antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography‐tandem mass spectrometry
6个月前
已完结
Transition of average drug‐to‐antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography‐tandem mass spectrometry
6个月前
已完结
A simultaneous analysis of the time-course of leukocytes and neutrophils following docetaxel administration using a semi-mechanistic myelosuppression model
6个月前
已完结
Model of Chemotherapy-Induced Myelosuppression With Parameter Consistency Across Drugs
6个月前
已完结
皖公网安备34019202002308
